Jeremy Sen
Overview
Explore the profile of Jeremy Sen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
17
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Karpen R, Sen J, Wall S, Musson S, Tossey J
Leuk Res
. 2023 Dec;
136:107431.
PMID: 38043326
Background: Limited data are available regarding efficacious antiemetic regimens to prevent chemotherapy-induced nausea and vomiting (CINV) for patients undergoing allogeneic hematopoietic stem cell transplant (HSCT). In patients aged 60 years...
2.
Courville E, Shantzer L, Vitzthum von Eckstaedt H, Mellot H, Keng M, Sen J, et al.
Lab Med
. 2021 Jul;
53(1):95-99.
PMID: 34268555
Variant acute promyelocytic leukemia (vAPL) is a rare leukemia characterized by rearrangement between RARα and a non-PML partner gene. This type of leukemia can be difficult to recognize by histomorphologic...
3.
Reed D, Sen J, Lassiter K, Thomas T, Harr E, Daniels E, et al.
JCO Oncol Pract
. 2020 Feb;
16(3):e306-e312.
PMID: 32048944
Purpose: Mucosal barrier injury (MBI) occurs during periods of prolonged neutropenia in patients receiving cytotoxic chemotherapy for hematologic malignancies. This can lead to laboratory-confirmed bloodstream infections (LCBIs) and subsequent complications,...
4.
Man L, Sen J, Giordano J, McLoughlin E, Morris A, DeGregory K, et al.
J Oncol Pract
. 2019 Jun;
15(8):e728-e732.
PMID: 31237807
There are no national standards for time between patient arrival and the initiation of scheduled chemotherapy (time to chemotherapy [TTC]). Delays in this process have a negative impact on patient...
5.
Morris A, Naeem M, Murray T, Sen J, Thomas T, Daniels E, et al.
J Oncol Pract
. 2018 Nov;
:JOP1800307.
PMID: 30433844
Purpose:: Twenty percent of patients with acute myeloid leukemia (AML) undergoing induction or reinduction chemotherapy at the University of Virginia Health System from May 2011 to August 2014 had a...
6.
Walsh M, Hanna S, Sen J, Rawal S, Cabral C, Yurkovetskiy A, et al.
Clin Cancer Res
. 2012 Mar;
18(9):2591-602.
PMID: 22392910
Purpose: To evaluate the pharmacokinetics and tissue disposition of macromolecular camptothecin (CPT) drug conjugate, XMT-1001, and irinotecan (CPT-11) in mice bearing HT-29 xenograft tumors. Experimental Design: The antitumor efficacy of...